Search Results

CSL is committed to providing information in a way that is accessible and understandable for all, regardless of any disability.

https://www.csl.com/accessibility-statement

As we approach the OPTIONS XII for the Control of Influenza, a global scientific meeting that focuses on influenza, there is an enormous sense of pride among all of us at CSL Seqirus.

https://newsroom.csl.com/2024-09-26-OPTIONS-XII-IS-COMING-HOME

The coagulation factor replacement therapy will be manufactured at CSL's Lengnau plant in Switzerland with the sole intent of being donated to the WFH.

https://newsroom.csl.com/2022-04-28-CSL-Behring-Donates-500-Million-International-Units-of-Coagulation-Factor-Replacement-Therapy-to-the-World-Federation-of-Hemophilia-Humanitarian-Aid-Program-to-Help-Those-Living-with-Bleeding-Disorders

The positive CHMP opinion for sparsentan is one step closer to bringing this treatment option to patients in Europe with IgAN, a rare and serious condition that can cause kidney disease," said Emmanuelle Lecomte Brisset, Senior Vice President and Head of Global Regulatory Affairs at CSL.

https://newsroom.csl.com/2024-02-23-CSL-Vifor-and-Travere-Therapeutics-announce-sparsentan-receives-positive-CHMP-opinion-for-the-treatment-of-IgA-nephropathy

At CSL, we are driven by our promise to patients around the world and together with our partners, we are committed to further building awareness, helping patients recognize their symptoms, and improving access to care.

https://newsroom.csl.com/2023-11-24-Iron-Deficiency-Day-2023-CSL-Vifor-calls-for-access-to-iron-deficiency-diagnosis-and-treatment

At CSL Seqirus, we are dedicated to remaining at the front line of public health and will persist in closely monitoring the avian influenza developments in collaboration with our global partners.

https://newsroom.csl.com/2024-05-30-On-Pandemic-Preparedness

Understand our aim to develop the next generation of influenza vaccines and how we're working to unite product platforms across the globe.

https://www.csl.com/we-are-csl/our-businesses-and-products/csl-seqirus/csl-seqirus-manufacturing/csl-seqirus-manufacturing-technical-development

CSL Vifor has treatments to treat iron deficiency, a condition in which iron levels are below the minimal threshold.

https://www.csl.com/patients-public-health/iron-deficiency

To report an undesirable effect or adverse event, please contact CSL Behring today.

https://www.csl.com/contact/report-a-behring-undesirable-effect

Next-generation mRNA technology serves as one of our strategic scientific platforms at CSL and in our evaluation of Arcturus, we saw the right external innovation to strategically complement our in-house next-generation mRNA capabilities and reinforce our longstanding leadership in influenza.

https://newsroom.csl.com/2022-12-12-CSL-Announces-Closing-of-Global-Collaboration-and-Licensing-Agreement-with-Arcturus-Therapeutics